Compounds > masoprocol

masoprocol and Lung Neoplasms

masoprocol has been researched along with Lung Neoplasms in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (28.57)	18.2507
2000's	2 (28.57)	29.6817
2010's	3 (42.86)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cai, Y; Ding, T; Ji, J; Jiang, X; Li, W; Li, X; Liang, G; Tang, Q; Wei, T; Weng, B; Wu, J	1
Fang, B; Guo, W; Huang, P; Liu, J; Wang, L; Wei, X; Wu, S	1
Giacalone, NJ; Lu, B; Sun, Y	1
Bunjobpon, W; Fessler, S; Freer, IK; Glaser, M; Liu, T; McDonald, RW; Pardo, OE; Robins, DJ; Seckl, MJ	1
Ahn, MC; Braun, DP; Casey, L; Chu, E; Harris, JE; Siziopikou, KP; Wilbanks, G	1
Avis, IM; Boyle, T; Jett, M; Martínez, A; Moody, T; Mulshine, JL; Treston, AM; Vos, MD	1
Dorr, RT; Lambert, JD; Meyers, RO; Timmermann, BN	1

Other Studies

7 other study(ies) available for masoprocol and Lung Neoplasms

Article	Year
Discovery and anti-cancer evaluation of two novel non-ATP-competitive FGFR1 inhibitors in non-small-cell lung cancer. BMC cancer, 2015, Apr-12, Volume: 15 Topics: Adenosine Triphosphate; Animals; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Drug Discovery; Humans; Lung Neoplasms; Masoprocol; Mice; Phosphorylation; Protein Kinase Inhibitors; Receptor, Fibroblast Growth Factor, Type 1; Xenograft Model Antitumor Assays	2015
Oxidative stress in NSC-741909-induced apoptosis of cancer cells. Journal of translational medicine, 2010, Apr-16, Volume: 8 Topics: Antioxidants; Apoptosis; Caspase 8; Cell Line, Tumor; Cell Proliferation; Cluster Analysis; Drug Screening Assays, Antitumor; Dual-Specificity Phosphatases; Enzyme Activation; Humans; Indoles; Inhibitory Concentration 50; JNK Mitogen-Activated Protein Kinases; Lung Neoplasms; Masoprocol; Mitogen-Activated Protein Kinase Phosphatases; Oxidative Stress; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-jun; Reactive Oxygen Species; RNA, Small Interfering	2010
Terameprocol (tetra-O-methyl nordihydroguaiaretic acid), an inhibitor of Sp1-mediated survivin transcription, induces radiosensitization in non-small cell lung carcinoma. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2011, Volume: 6, Issue:1 Topics: Apoptosis; Blotting, Western; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Proliferation; Gene Expression Regulation, Neoplastic; Humans; Inhibitor of Apoptosis Proteins; Lung Neoplasms; Masoprocol; Radiation-Sensitizing Agents; Sp1 Transcription Factor; Survivin; Tumor Cells, Cultured; Tumor Stem Cell Assay	2011
Synthesis and anticancer activity of nordihydroguaiaretic acid (NDGA) and analogues. Anti-cancer drug design, 2001, Volume: 16, Issue:6 Topics: Antineoplastic Agents; Carcinoma, Small Cell; Cell Division; Humans; Inhibitory Concentration 50; Lipoxygenase Inhibitors; Lung Neoplasms; Masoprocol; Oxidation-Reduction; Structure-Activity Relationship; Tumor Cells, Cultured	2001
Sensitivity of tumoricidal function in macrophages from different anatomical sites of cancer patients to modulation of arachidonic acid metabolism. Cancer research, 1993, Jul-15, Volume: 53, Issue:14 Topics: 6-Ketoprostaglandin F1 alpha; Arachidonic Acid; Carcinoma, Non-Small-Cell Lung; Dinoprostone; Humans; Indomethacin; Lung Neoplasms; Macrophages; Masoprocol; Monocytes; SRS-A	1993
Growth control of lung cancer by interruption of 5-lipoxygenase-mediated growth factor signaling. The Journal of clinical investigation, 1996, Feb-01, Volume: 97, Issue:3 Topics: 5-Lipoxygenase-Activating Proteins; Animals; Arachidonate 5-Lipoxygenase; Arachidonic Acid; Base Sequence; Carcinoma, Small Cell; Carrier Proteins; Cell Division; Gastrin-Releasing Peptide; Growth Substances; Lipoxygenase Inhibitors; Lung Neoplasms; Masoprocol; Membrane Proteins; Mice; Mice, Nude; Molecular Sequence Data; Peptides; RNA, Messenger; Signal Transduction; Somatomedins	1996
tetra-O-methylnordihydroguaiaretic acid inhibits melanoma in vivo. Cancer letters, 2001, Sep-28, Volume: 171, Issue:1 Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Breast Neoplasms; Cell Cycle; Colonic Neoplasms; DNA Replication; Female; Intracellular Membranes; Kidney; Liver; Lung Neoplasms; Male; Masoprocol; Melanoma; Melanoma, Experimental; Membrane Potentials; Mice; Mice, Inbred C57BL; Mice, SCID; Mitochondria; Neoplasm Transplantation; Tumor Cells, Cultured; Xenograft Model Antitumor Assays	2001